Skip to main content
Figure 8 | Molecular Cancer

Figure 8

From: An integrative model for recurrence in ovarian cancer

Figure 8

Independent TaqMan® PCR validation of a set of selected genes from both cohorts in a test set of serous papillary adenocarcinomas of varying grade and stage. BTC and FGF2 provided the best distinction between recurrent and primary tumours with fold changes of 2.8 and 2.71 respectively.

Back to article page

Molecular Cancer

ISSN: 1476-4598